György Krasznai | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where György Krasznai is active.

Explore More

Publication

Featured researches published by György Krasznai.

Archive | 2001

A process for the preparation of quetiapine and intermediates therefor

Daniel Bozsing; Lax Györgyi Koványiné; Gyula Simig; Györgyné Rákóczy; Peter Tompe; György Krasznai; Donáth Györgyi Vereczkeyné; Kalman Nagy

Archive | 1999

Process for the preparation of sertraline and its 1,r-stereoisomer

Nagy Peter Kotay; Jozsef Barkoczy; Gyula Simig; György Krasznai; Kalman Nagy; Donáth Györgyi Vereczkeyné; Norbert Nemeth; Tibor Szabo; Ilona Sztruhar; Laszlo Ladanyi; Laszlo Balazs; Imre Doman; Zoltan Greff; Zoltan Ratkai; Péter Seres

Archive | 1998

Process for the preparation of a dihydropyridine derivative

Daniel Bozsing; Gyorgyi Kovanyi; Gyula Simig; György Krasznai; Gabor Blasko; Peter Tompe; Kalman Nagy; Györgyi Donáth Vereczkey; Gabor Nemei; Norbert Nemeth

Archive | 1998

A process and intermediate compounds for the preparation of amlodipine benzene sulphonate

Gábor Dr. Blask; Daniel Bozsing; Györgyi Lax Dr. Koványi; György Krasznai; Kalman Nagy; Gábor Német; Norbert Nemeth; Gyula Simig; Peter Tompe; Györgyi Donáth Vereczkey

Archive | 2012

PROCESS FOR THE PREPARATION OF A RIVAROXABAN AND INTERMEDIATES FORMED IN SAID PROCESS

Éva Sipos; Gyorgyi Kovanyine Lax; Balázs Havasi; Balázs Volk; György Krasznai; György Ruzsics; Jozsef Barkoczy; Mária Tóthné Lauritz; Gyula Lukács; András Boza; László József Hegedüs; Mária Tóth; Eva Pecsi

Archive | 2000

Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof

Gyula Lukács; Gyula Simig; Tibor Mezei; Zoltan Budai; Márta Porcs-Makkay; György Krasznai; Kalman Nagy; Györgyi Donáth Vereczkey; Tibor Szabo; Norbert Nemeth; János Szulágyi

Archive | 2005

Process for preparation of high-purity meloxicam and meloxicam potassium salt

Tibor Mezei; Gyula Simig; Enikö Molnár; Gyula Lukács; Márta Porcs-Makkay; Balázs Volk; Valéria Hofmanné Fekete; Kalman Nagy; Norbert Mesterhazy; György Krasznai; Gyorgyi Vereczkeyne Donath; Gyuláné Körtvélyessy; Eva Pecsi

Archive | 2001

High purity (1R, 2S, 4R) -(-) -2- [ (2' -{N,N-dimethylamino} -ethoxy) ] -2- [phenyl] -1, 7,7 -tri - [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof and a process for the preparation of these compounds as well as medicaments containing 1 or more of these compounds and their use

Gyula Lukács; Gyula Simig; Tibor Mezei; Zoltan Budai; Márta Porcs-Makkay; György Krasznai; Kalman Nagy; Györgyi Donáth Vereczkey; Tibor Szabo; Norbert Nemeth; János Szulágyi

Archive | 2000

High purity (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof

Gyula Lukács; Gyula Simig; Tibor Mezei; Zoltan Budai; Márta Porcs-Makkay; György Krasznai; Kalman Nagy; Györgyi Donáth Vereczkey; Tibor Szabo; Norbert Nemeth; János Szulágyi

Archive | 2011

Method for the preparation of high-purity pharmaceutical intermediates

Lax Györgyi Koványiné; Gyula Simig; Balázs Volk; Ferenc Bartha; György Krasznai; György Ruzsics; Éva Sipos; Kalman Nagy; György Morovján; Jozsef Barkoczy; Adrienn Keszthelyi; Janos Imre; Gábor Bagyinszki

Explore More